Efficacy and safety of an herbal formula (KBMSI-2) in the treatment of erectile dysfunction: A preliminary clinical study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of an herbal formula (KBMSI-2) in the treatment of erectile dysfunction: A preliminary clinical study

Published:2019 Issue:4 Volume:60 Page:275
ISSN:2466-0493
Container-title:Investigative and Clinical Urology
language:en
Short-container-title:Investig Clin Urol

Author:

Park Nam Cheol¹²,Kim Sae Woong³,Hwang Sung Yeoun⁴,Park Hyun Jun¹²^ORCID

Affiliation:

1. Department of Urology, Pusan National University School of Medicine, Busan, Korea.

2. Medical Research Institute of Pusan National University Hospital, Busan, Korea.

3. Catholic Integrative Medicine Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea.

4. Korea Bio Medical Science Institute, Seoul, Korea.

Publisher

The Korean Urological Association

Subject

Urology

Link

https://synapse.koreamed.org/pdf/10.4111/icu.2019.60.4.275

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antioxidant Supplementation for Erectile Dysfunction: Systematic Review and Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials;The World Journal of Men's Health;2024

2. Safety and Efficacy Assessment of Red Ginseng Oil (RXGIN) in Men with Lower Urinary Tract Symptoms in a Randomized, Double-Blind, Placebo-Controlled Trial;The World Journal of Men's Health;2024

3. Botanical drugs for treating erectile dysfunction: clinical evidence;Frontiers in Pharmacology;2023-08-16

4. An overview of the history, current strategies, and potential future treatment approaches in erectile dysfunction: a comprehensive review;Sexual Medicine Reviews;2023-04-19

5. Quisqualis indica extract for men with lower urinary tract symptoms: A randomized, double-blind, placebo-controlled trial;Investigative and Clinical Urology;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3